Programa de Pós-Graduação em Biologia de Agentes Infecciosos e Parasitários - PPGBAIP/ICB
URI Permanente desta comunidadehttps://repositorio.ufpa.br/handle/2011/4696
O Programa de Pós-Graduação em Biologia de Agentes Infecciosos e Parasitários (PPGBAIP) é um programa do Instituto de Ciências Biológicas (ICB) da Universidade Federal do Pará (UFPA). O PPGBAIP contempla a formação de profissionais das áreas das Ciências Biológicas, Biomédicas, Médicas e afins em nível de mestrado e doutorado.
Navegar
Navegando Programa de Pós-Graduação em Biologia de Agentes Infecciosos e Parasitários - PPGBAIP/ICB por CNPq "CNPQ::CIENCIAS BIOLOGICAS::IMUNOLOGIA"
Agora exibindo 1 - 2 de 2
- Resultados por página
- Opções de Ordenação
Tese Acesso aberto (Open Access) Estudo da ação da crotoxina sobre o perfil de ativação de macrófagos peritoneais infectados com Leishmania (Leishmania) amazonensis(Universidade Federal do Pará, 2016-04-12) FARIAS, Luis Henrique Seabra de; SILVA, Edilene Oliveira da; http://lattes.cnpq.br/7410116802190343American Tegumentary Leishmaniasis (ATL) is a parasitic disease widely spread in most countries of Latin America, and caused by different species of the genus Leishmania. This protozoan is an obligate intracellular parasite that developed mechanisms to subvert the microbicidal activity of macrophages, such as inhibition of reactive oxygen species (ROS) and nitric oxide (NO) production. The chemotherapy is one of the most effective treatments for this disease, although the antileishmanial drugs available are in general toxic, expensive and require long-term treatment. Thus, the development of new natural products to treat leishmaniasis has become a priority. Ophidian toxins are natural sources of bioactive products with therapeutic properties already described. Therefore, we considered analyze the activity of crotoxin (CTX), a dimeric protein and the main neurotoxic component of Crotalus durissus terrificus snake venom, against promastigotes of Leishmania (L.) amazonensis and macrophages. The toxin significantly decreasing of 32,5% on the growth of promastigotes at 1,2μg/mL and 24,9% at 4,8μg/mL after 96 hours of treatment (IC50= 22,86μg/mL). The colorimetric assay (MTT) showed that this compound presented no cytotoxic effects against macrophages. Interestingly, CTX treated macrophages presented a significant higher capacity to metabolize the MTT substrate (mean= 59,78% ±3,31, higher) when compared with untreated control. It was observed that treated macrophages presented intense production of ROS (mean= 35,95% ±2,76, higher) when compared with untreated cells. Treated macrophages presented increased phagocytic activity and were capable to eliminate intracellular parasites. Besides that, these cells had it NO and pro-inflammatory cytokines production increased and morphological alteration that characterizes the M1 cellular activation profile. That activation culminates with the parasite elimination throughout host response, reverting the anergic action promoted by L. amazonensis, thereby leading to a good disease prognostic, evidencing that this compound could be a promising antileishmanial agent.Dissertação Acesso aberto (Open Access) Investigação do polimorfismo do exon - 1 do gene MBL (Mannose-Binding Lectin) em pacientes portadores de tuberculose(Universidade Federal do Pará, 2009-03-31) ARAÚJO, Mauro Sérgio Moura de; VALLINOTO, Antonio Carlos Rosário; http://lattes.cnpq.br/3099765198910740Mannose-binding lectin (MBL) is considered an acute phase protein with important role in the first line of defense of the innate immune system, whose serum levels are genetically determined. The MBL activates the lectin pathway of complement, and mediate the phagocytosis of microorganisms and opsonization. Several studies have associated serum levels of MBL to susceptibility or resistance to infectious agents including the Mycobacterium tuberculosis, causative agent of human tuberculosis. Aiming to evaluate the occurrence of a possible association between MBL gene polymorphisms and tuberculosis, it was evaluated the frequencies of mutations in exon 1 of MBL gene in a group of 167 TB patients, divided into 3 groups: patients with pulmonary tuberculosis, with extrapulmonary tuberculosis, patients with multiresistant tuberculosis to drugs and the control group with 159 health professionals. The identification of alleles MBL*A, *B, *C and *D was performed by polymerase chain reaction, using specific sequences of primers and subsequent enzymatic digestion. The analysis of allelic and genotypic frequencies of exon 1 did not show any significant difference between patients with tuberculosis and control group (p> 0.05). There were no significant associations between groups of pulmonary tuberculosis, extrapulmonary tuberculosis and multidrug drug among themselves and when connected to the control group. Data from our study showed no evidence of any influence of variations in the exon 1 of MBL gene in active tuberculosis, suggesting that the gene polymorphism has no influence on susceptibility to tuberculosis.